Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical PK 1999 Phase I pharmacokinetics in healthy human volunteers (IV) Gobburu, Agers, Jusko, and Ynddal reported dose-proportional pharmacokinetics across five IV dose levels (4.21140.45 nmol/kg) in eight healthy male volunteers per level
November 14, 2025: Change in Medicare Coverage Means 10 Million More People Could Have Zepbound Covered Changes in Medicare coverage will give about 10 million people better access to Zepbound
Pregnancy and lactation: Safety is not yet clear
All sales final
The trajectory depends on how elevated your glucose was before starting treatment and how quickly tirzepatide brings it down
US$ 29.32
US$ 27.82
US$ 29.57
US$ 23.49
